Singapore markets open in 4 hours 58 minutes

CVS Health Corporation (CVS)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
55.65-1.79 (-3.12%)
At close: 03:59PM EDT
55.65 0.00 (0.00%)
After hours: 04:02PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
7,321,000
8,344,000
4,311,000
8,001,000
7,179,000
-
Depreciation & amortisation
4,503,000
4,366,000
4,224,000
4,486,000
4,441,000
-
Deferred income taxes
-1,048,000
-676,000
-2,029,000
-402,000
-570,000
-
Stock-based compensation
622,000
588,000
447,000
484,000
400,000
-
Change in working capital
-1,301,000
15,000
6,818,000
3,857,000
3,159,000
-
Accounts receivable
-2,501,000
-6,260,000
-2,971,000
-2,703,000
-1,510,000
-
Inventory
2,065,000
1,233,000
-1,435,000
735,000
-973,000
-
Accounts payable
3,411,000
3,618,000
4,260,000
2,898,000
2,769,000
-
Other working capital
8,139,000
10,395,000
13,450,000
15,745,000
13,428,000
-
Other non-cash items
-
416,000
332,000
-390,000
72,000
-
Net cash provided by operating activities
10,891,000
13,426,000
16,177,000
18,265,000
15,865,000
-
Cash flows from investing activities
Investments in property, plant and equipment
-2,752,000
-3,031,000
-2,727,000
-2,520,000
-2,437,000
-
Acquisitions, net
-9,543,000
-16,612,000
-1,388,000
-146,000
-866,000
-
Purchases of investments
-10,230,000
-9,043,000
-7,746,000
-9,963,000
-9,639,000
-
Sales/maturities of investments
7,991,000
7,729,000
6,729,000
7,246,000
6,467,000
-
Other investing activities
65,000
68,000
85,000
122,000
-
42,000
Net cash used for investing activities
-14,469,000
-20,889,000
-5,047,000
-5,261,000
-5,534,000
-
Cash flows from financing activities
Debt repayment
-7,822,000
-8,166,000
-4,211,000
-10,254,000
-15,631,000
-
Common stock repurchased
-3,021,000
-2,012,000
-3,500,000
0
-
-
Dividends paid
-3,193,000
-3,132,000
-2,907,000
-2,625,000
-2,624,000
-
Other financing activities
-284,000
-382,000
-449,000
-13,000
337,000
-
Net cash used provided by (used for) financing activities
-1,270,000
2,683,000
-10,516,000
-11,356,000
-7,696,000
-
Net change in cash
-4,848,000
-4,780,000
614,000
1,648,000
2,635,000
-
Cash at beginning of period
14,955,000
13,305,000
12,691,000
11,043,000
8,408,000
-
Cash at end of period
10,107,000
8,525,000
13,305,000
12,691,000
11,043,000
-
Free cash flow
Operating cash flow
10,891,000
13,426,000
16,177,000
18,265,000
15,865,000
-
Capital expenditure
-2,752,000
-3,031,000
-2,727,000
-2,520,000
-2,437,000
-
Free cash flow
8,139,000
10,395,000
13,450,000
15,745,000
13,428,000
-